Kaplan–Meier survival analysis further revealed that high SERPINB6 expression correlated with lower overall survival (OS), disease‐specific survival (DSS), and progression‐free interval (PFI) in glioma patients (Figure 2A–C). Here, SERPINB6 is linked to central nervous system cancer.